Aurora Cannabis Inc. produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products. It also operates CanvasRX, a network of cannabis counseling and outreach centers; and provides cannabis analytical product testing services. As of February 26, 2019, the company had operations in 24 countries across five continents. Aurora Cannabis Inc. has collaboration agreements with PharmaChoice, Pharmasave, and Shoppers Drug Mart for the distribution, sale, and marketing of medical cannabis products through their respective networks of pharmacies. The company has a strategic agreements with Hempco Food and Fiber Inc.; CTT Pharmaceuticals Inc.; Choom Holdings Inc.; Capcium Inc.; The Green Organic Dutchman Holdings Ltd.; Société des Alcools du Québec; Alcanna; Radient Technologies; Micron Waste; Wagner Dimas; Evio; and Cann Group Limited. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone1-855-279-4652
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$215.10 million
Profitability
Miscellaneous
Employees2,779
Next Earnings Date2/10/2020 (Estimated)
OptionableOptionable
Aurora Cannabis (NYSE:ACB) Frequently Asked Questions
What is Aurora Cannabis' stock symbol?
Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."
How were Aurora Cannabis' earnings last quarter?
Aurora Cannabis Inc (NYSE:ACB) released its earnings results on Thursday, November, 14th. The company reported $0.01 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.04. The firm had revenue of $57.02 million for the quarter, compared to the consensus estimate of $72.82 million. Aurora Cannabis had a negative return on equity of 2.97% and a negative net margin of 124.57%. View Aurora Cannabis' Earnings History.
When is Aurora Cannabis' next earnings date?
What price target have analysts set for ACB?
15 brokerages have issued twelve-month target prices for Aurora Cannabis' stock. Their forecasts range from $3.00 to $13.50. On average, they expect Aurora Cannabis' share price to reach $7.14 in the next twelve months. This suggests a possible upside of 193.7% from the stock's current price. View Analyst Price Targets for Aurora Cannabis.
What is the consensus analysts' recommendation for Aurora Cannabis?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 sell rating, 6 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aurora Cannabis.
Has Aurora Cannabis been receiving favorable news coverage?
Press coverage about ACB stock has trended extremely positive on Sunday, InfoTrie reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aurora Cannabis earned a media sentiment score of 5.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Aurora Cannabis.
Who are some of Aurora Cannabis' key competitors?
Some companies that are related to Aurora Cannabis include Canopy Growth (CGC), STADA Arzneimittel (STDAF), Cronos Group (CRON), Tilray (TLRY), USANA Health Sciences (USNA), Canopy Rivers (RIV), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN) and True Drinks (TRUU).
What other stocks do shareholders of Aurora Cannabis own?
Who are Aurora Cannabis' key executives?
Aurora Cannabis' management team includes the folowing people:
- Mr. Michael Singer, Exec. Chairman (Age 54)
- Mr. Terry Booth, Founder, CEO & Director (Age 54)
- Mr. Stephen Dobler, Founder, Pres & Director (Age 54)
- Mr. Glen Ibbott, Chief Financial Officer
- Mr. Allan John Cleiren C.A., ICD.D., Chief Operating Officer
Who are Aurora Cannabis' major shareholders?
Aurora Cannabis' stock is owned by a number of of retail and institutional investors. Top institutional investors include CIBC Asset Management Inc (0.07%), Commonwealth Equity Services LLC (0.06%), Cambridge Investment Research Advisors Inc. (0.04%), Pictet Asset Management Ltd. (0.03%), Commerzbank Aktiengesellschaft FI (0.02%) and USA Mutuals Advisors Inc. (0.02%).
Which major investors are selling Aurora Cannabis stock?
ACB stock was sold by a variety of institutional investors in the last quarter, including CIBC Asset Management Inc, Colony Group LLC, Virtu Financial LLC, Commerzbank Aktiengesellschaft FI, Commonwealth Equity Services LLC, Creative Planning, Janney Montgomery Scott LLC and Regal Investment Advisors LLC.
Which major investors are buying Aurora Cannabis stock?
ACB stock was acquired by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc., USA Mutuals Advisors Inc., Man Group plc, SG Americas Securities LLC, Penserra Capital Management LLC, Sunbelt Securities Inc., Tower Research Capital LLC TRC and Texas Yale Capital Corp..
How do I buy shares of Aurora Cannabis?
Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Aurora Cannabis' stock price today?
One share of ACB stock can currently be purchased for approximately $2.43.
How big of a company is Aurora Cannabis?
Aurora Cannabis has a market capitalization of $2.65 billion and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.View Additional Information About Aurora Cannabis.
What is Aurora Cannabis' official website?
How can I contact Aurora Cannabis?
Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]
MarketBeat Community Rating for Aurora Cannabis (NYSE ACB)
MarketBeat's community ratings are surveys of what our community members think about Aurora Cannabis and other stocks. Vote "Outperform" if you believe ACB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACB will underperform the S&P 500 over the long term. You may vote once every thirty days.
